PRINCIPAL FINANCIAL GROUP INC - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 266 filers reported holding MIRATI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.6%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$633,561
+28.1%
10,784
-5.0%
0.00%
Q3 2023$494,450
+24.5%
11,351
+3.2%
0.00%
Q2 2023$397,285
-12.2%
10,996
-9.7%
0.00%
Q1 2023$452,555
-20.0%
12,172
-2.5%
0.00%
Q4 2022$565,560
-28.3%
12,482
+10.6%
0.00%
-100.0%
Q3 2022$789,000
+9.0%
11,290
+4.6%
0.00%0.0%
Q2 2022$724,000
-12.7%
10,791
+7.0%
0.00%0.0%
Q1 2022$829,000
-45.9%
10,088
-3.4%
0.00%0.0%
Q4 2021$1,532,000
-38.5%
10,440
-25.9%
0.00%
-50.0%
Q3 2021$2,491,000
-3.2%
14,083
-11.6%
0.00%0.0%
Q2 2021$2,573,000
-73.5%
15,931
-71.9%
0.00%
-71.4%
Q1 2021$9,720,000
+84.6%
56,743
+136.7%
0.01%
+75.0%
Q4 2020$5,265,000
+37.3%
23,970
+3.8%
0.00%
+33.3%
Q3 2020$3,835,000
+41.7%
23,094
-2.6%
0.00%
+50.0%
Q2 2020$2,707,000
+104.1%
23,707
+37.4%
0.00%
+100.0%
Q1 2020$1,326,000
-30.9%
17,248
+15.9%
0.00%
-50.0%
Q4 2019$1,918,000
+66.1%
14,884
+0.4%
0.00%
+100.0%
Q3 2019$1,155,000
-19.7%
14,832
+6.1%
0.00%0.0%
Q2 2019$1,439,000
+56.2%
13,975
+11.3%
0.00%0.0%
Q1 2019$921,000
+336.5%
12,559
+180.8%
0.00%
Q3 2018$211,000
+0.5%
4,473
+5.2%
0.00%
Q2 2018$210,0004,2510.00%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$257,839,00068.01%
Boxer Capital, LLC 2,000,000$164,440,0008.45%
Avoro Capital Advisors LLC 5,325,000$437,822,0007.99%
M28 Capital Management LP 82,900$6,816,0006.27%
Artal Group S.A. 1,350,000$110,997,0004.65%
Nextech Invest Ltd. 173,300$14,249,0004.07%
Perceptive Advisors 2,380,710$195,742,0003.92%
Logos Global Management LP 350,000$28,777,0003.73%
Camber Capital Management LP 1,200,000$98,664,0003.57%
RTW INVESTMENTS, LP 1,561,497$128,386,0002.66%
View complete list of MIRATI THERAPEUTICS INC shareholders